Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment Failure()

OBJECTIVE: Asian melanoma patients, predominantly comprised of acral and mucosal subtypes, might not benefit from immunotherapy and targeted therapy as much as Caucasian patients. Novel treatment strategies are demanded after conventional treatment failure. This was a prospective, single-arm, and si...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, ChuanLiang, Zhou, Li, Lian, Bin, Si, Lu, Sheng, XiNan, Chi, ZhiHong, Kong, Yan, Wang, Xuan, Tang, BiXia, Mao, LiLi, Li, SiMing, Dai, Jie, Yan, XieQiao, Bai, Xue, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080644/
https://www.ncbi.nlm.nih.gov/pubmed/30056366
http://dx.doi.org/10.1016/j.tranon.2018.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080644/
https://www.ncbi.nlm.nih.gov/pubmed/30056366
http://dx.doi.org/10.1016/j.tranon.2018.07.009

Ejemplares similares